9.635

0.31% -0.065

Xeris Biopharma Holdings Inc (XERS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Xeris Biopharma Holdings Inc-Aktie (XERS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	19.00% 71.54	60.12	60.10	54.27	48.06
Operating Expenses	6.09% 67.06	63.21	58.42	67.16	56.25
Benefits Costs and Expenses	-	-	260.17	-	-
Costs And Expenses	6.09% 67.06	63.21	81.88	67.16	56.25
Operating Income/Loss	245.05% 4.482	-3.09	1.679	-12.89	-8.187
Income/Loss From Continuing Operations Before Tax	875.91% 71.54	-9.22	-200.07	54.27	-15.01
Income Tax Expense/Benefit, Deferred	-	-	-	-3.324	0.749
Income Tax Expense/Benefit	-	-	-	-3.324	0.749
Income/Loss From Continuing Operations After Tax	79.09% -1.928	-9.22	-5.113	-15.74	-15.01
Net Income/Loss	79.09% -1.928	-9.22	-5.113	-15.74	-15.01
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4.60% 159.46	152.45	0.8106	148.99	148.35
Diluted Average Shares	4.60% 159.46	152.45	0.8106	148.99	148.35
Basic Earnings Per Share	83.33% -0.01	-0.06	-0.03	-0.11	-0.10
Diluted Earnings Per Share	83.33% -0.01	-0.06	-0.03	-0.11	-0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.23

0.68%

INCY

$92.89

0.72%

GMAB

$28.92

0.96%

BNTX

$104.39

0.46%

ONC

$312.02

0.74%

INSM

$182.66

3.82%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters